pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4270 |
Genomic Coordinates | chr3: 15496239 - 15496308 |
Description | Homo sapiens miR-4270 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4270 | ||||||||||||||||||
Sequence | 11| UCAGGGAGUCAGGGGAGGGC |30 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | RAPGEF1 | ||||||||||||||||||||
Synonyms | C3G, GRF2 | ||||||||||||||||||||
Description | Rap guanine nucleotide exchange factor 1 | ||||||||||||||||||||
Transcript | NM_005312 | ||||||||||||||||||||
Other Transcripts | NM_198679 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on RAPGEF1 | |||||||||||||||||||||
3'UTR of RAPGEF1 (miRNA target sites are highlighted) |
>RAPGEF1|NM_005312|3'UTR 1 GAGCAGACGCCGGGATCCAGGAGAATGCTCGAGGGGCGCAGAGGGCAGCTCCCAGACCGGAGAGGACCTTGGACCTGTTA 81 GGCGCATGGCAGGAGTCCCGGCCTCGGAGCCATGAGGCTGGCCAGCCCTCAGCGGGGCCGGGCGGGAGCTGGAGCCTGCC 161 AGCCGCTTCCTGCCTCCTTCCTCTGTGGGAGCAGACCCGTGGGCCTCAGGGCAGCCAGCAGGCAGGTCTTGTTGCCAATT 241 TACAAACCGGTGGTTTTCTGGTTTGGTTTTGTTTTCTGCTTTTACTTCCATCTCTCCCCTCTTGACCTTCCACCCACTCC 321 CCTCCAGGGAGAGAGCAGCAGAGACCTCATCAGCAGACCAAGGAAGTGGTGGGTGCTCCCCCTCCCTAAGCTCCAGGGTC 401 CCTGAATCTTCTGAAATCTCAAATGAGTGGAGGCCTCCTGGGGTGGCCTGTCCTGCAGGGGCCCTGGAATGGGGGCAAGC 481 AGCTGGGTGGGCAGAATGCAGAGTAGACTCGGGGGAGGATCCTTTCACTTTCCGCTTCCCCTTCTGATGCATGGAGGATG 561 GTGTGAGCTTTTCAGCAGGCCCGGAAAGGTACGCAGGTGACGCCTTAGCAGCCCCGCAGCTGGTGCTCTGCCCCGCGGTA 641 CTGGCGCCATCAGGGCCTCCCTTGCCCGCCTGAGAGCAGCAGCAGTCTCTGTCATCCCGTCGCCCCTTACCCCCCACCCC 721 AGGCCACTGGGCCCCTCCCACACCACCTGGGGAGCTGAGAAGAGGAGGCTGGAGTAAGGGAGGACTTGATCATCCAAGAA 801 ATACTTTTTATTGCTGGGAGTCTTCTGAACCTCACCAAACTGAGGCCAGAGCTGAGCTCCTGGGGGAGTTAATTCAGAGG 881 GGAGAGGCCAGCACCTCCCTCCTCCATCGCTCGCTGTGTGCCTTAAACTCCATCTCATGTCCCTCCCCATCCCCTGGCTT 961 TCCCTCCCTCCTTGCCCCATCCTGGGCCAGCCAGCAGGGCTCCTCCTCTGGCTCTTCAGACCTTTCAGCCAGTGCTGTCA 1041 GTGCCCCTGGGAGGGAAGGGCATCCCTGAGGCACCCGAATGGTCCCTCAGGGTGCAGGGAGGCAGAAGCCTGGCCACAGA 1121 GGAGCCTCCTAAGGCAGCAGCTGCAGCAAGCGCACCCTCTCCCCACTCTCCCCACGCCAGAGCGGCTTCCAGAGCAGATG 1201 CTGTTTCCATCCTCCTCGTCAAAACCATTCTCGCTGCTGAGCTTGACAATCTGGGCAAGGCTTGTGGGGCGCTTGACAAA 1281 CAGAATCTGCCCTGTGCCGCCTGGTTCCGTGGCCTCCAGCATGAGCCTGCAGGCAGGGCGCTGCGGGAACCCAGTTGTGC 1361 TGCCCCAGCCCATGCCTCCGGGTCTGCTGTGCATGAATGAGTGCTCACTTGTCCCGGGTTTAGGACGTGGTCAAGTGAAC 1441 AGCAGGGTCTAACTGTGCTTACTTAGCCCAGTTCAAACAGAACAAAGGAAAAATATAGAAAGCAACATCTGTTGATCATT 1521 TAGGTTTTTTTTTAAACCACCATGTCACTTTGAGTCCTTCATGGGTTTTTGAACAGCATTTATCAAGAAGAAAATGTGGG 1601 CTTTTTCCCCTCTCCCGTGTTTTGTTTGTCCTGTAGATAGAGGGAGGAAAGCCGTGCAGTGGCAGGCGGGACCCCCTCTG 1681 GTGGCGGGACCCCCTCTTGCGGTGGTCTTGCGGGGCCAGCCGGGACCTGTCACTTTATTATTTAAGGAGTGTGTGTGTAG 1761 AGTCGCTGGCTTATTAACAGTATTGTGTGTGGGTTGGGTTTTTAGTTTGTTCCTTCTTTTTGAAGTCCCTTCATTTCAAT 1841 CCTTGACTCTCTCTCCCCTTCCCTTGCCCAGCTCTGTTGAATGCTGCTGTGCGCGTGTGAGGGCCGCTCTGCACACAGGG 1921 CCCTTGGGTTGTGTGAACTGAAATTCTCCCTGTATTTGTGAGACTCGCAGGAGTCCCCATCTGTAGCACAGGCAATGCCA 2001 GTGCCATGCTGCAGCCTCAGAAACCAGGCCTCTCACTCCAGCAGCAGGCAGAACCGTGTCTGTGGTCGGGTGCTGTCCAC 2081 AGCTCTGTCTGCCTTGTTCTTGGGCTTGAGCTGGATAGAGGTGGGGTCTCTTCACCTTCCCTGAATTCAGAACAGACCCT 2161 GTGCCTGGCCCCAGTGTGCCCAGGCAATTCCCCAGGCCCTCACTGGGAGCCCTTGGTGTTCTGAGCAGCAGGGCCCAGGC 2241 AGCACATGAGCAGTGCCCAGGGGCTCCCTGCGTGAGGACGGCAAGGTGCGATGTATGTCTAACTTATTGATGGCAGGCAG 2321 CCCCCTGTGCCCCCTAAGCCTGGCCCTGGTTATTGCTGAGCTCTGTGCTCAGTGCTGCGGCCTGGCCGTGGCTCGTCTGT 2401 TCCTTTGGGGGGCCCGGGCGGGTTGTGGGAATCAGTCTTCACAGACAGACGTGAGCCAGGCGGAGGACTCGTTCCTTGCA 2481 GAGGTCAGTCCTCACCTGCAGGTGTCGGGGTGGGGGGGGGCAAGGAGGGGCAGGCACACACCATGTCTGACCTGAACCCG 2561 ATTCTGGGGAGCATCTTCCCGCTCCGGCCCCACGACCTCCACAGGGTTACATTGTAATATATATGCCCCAGCTAACCTGT 2641 CTGATGGTGGCATCTTCCTGCAGACATTTCAAACATGTAACTTTTATATGAAAAAAAATAAACACAGATGAAAGCTGCCC 2721 AATGCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000372189.3 | 3UTR | CUCUUCACCUUCCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
146 hsa-miR-4270 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT056076 | PIP4K2A | phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | 2 | 2 | ||||||||
MIRT057833 | SLC30A7 | solute carrier family 30 member 7 | 2 | 2 | ||||||||
MIRT109295 | TXLNG | taxilin gamma | 2 | 2 | ||||||||
MIRT117521 | MIDN | midnolin | 2 | 2 | ||||||||
MIRT183504 | BTG2 | BTG anti-proliferation factor 2 | 2 | 2 | ||||||||
MIRT258346 | HOXA11 | homeobox A11 | 2 | 6 | ||||||||
MIRT275743 | TFDP1 | transcription factor Dp-1 | 2 | 2 | ||||||||
MIRT284426 | CAPN15 | calpain 15 | 2 | 2 | ||||||||
MIRT386430 | CCL22 | C-C motif chemokine ligand 22 | 2 | 2 | ||||||||
MIRT443374 | PLXNA2 | plexin A2 | 2 | 2 | ||||||||
MIRT445251 | SEMA5A | semaphorin 5A | 2 | 2 | ||||||||
MIRT445767 | CCND3 | cyclin D3 | 2 | 2 | ||||||||
MIRT447231 | ABI2 | abl interactor 2 | 2 | 2 | ||||||||
MIRT451224 | ZNF444 | zinc finger protein 444 | 2 | 2 | ||||||||
MIRT451433 | TJP3 | tight junction protein 3 | 2 | 4 | ||||||||
MIRT451959 | TMPRSS5 | transmembrane protease, serine 5 | 2 | 2 | ||||||||
MIRT452006 | FKBP5 | FK506 binding protein 5 | 2 | 2 | ||||||||
MIRT452300 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 2 | ||||||||
MIRT452717 | DTHD1 | death domain containing 1 | 2 | 2 | ||||||||
MIRT453361 | ZNF3 | zinc finger protein 3 | 2 | 2 | ||||||||
MIRT453458 | GLG1 | golgi glycoprotein 1 | 2 | 2 | ||||||||
MIRT453832 | SAA1 | serum amyloid A1 | 2 | 2 | ||||||||
MIRT453928 | COMMD5 | COMM domain containing 5 | 2 | 4 | ||||||||
MIRT454312 | ZNF134 | zinc finger protein 134 | 2 | 2 | ||||||||
MIRT454493 | SLC29A1 | solute carrier family 29 member 1 (Augustine blood group) | 2 | 2 | ||||||||
MIRT454836 | POLR2J3 | RNA polymerase II subunit J3 | 2 | 2 | ||||||||
MIRT455142 | TBC1D25 | TBC1 domain family member 25 | 2 | 2 | ||||||||
MIRT455922 | RAPGEF1 | Rap guanine nucleotide exchange factor 1 | 2 | 2 | ||||||||
MIRT456163 | TTF2 | transcription termination factor 2 | 2 | 2 | ||||||||
MIRT456395 | KLHL12 | kelch like family member 12 | 2 | 2 | ||||||||
MIRT456786 | MTHFSD | methenyltetrahydrofolate synthetase domain containing | 2 | 2 | ||||||||
MIRT457164 | MXRA7 | matrix remodeling associated 7 | 2 | 2 | ||||||||
MIRT457190 | ERC1 | ELKS/RAB6-interacting/CAST family member 1 | 2 | 2 | ||||||||
MIRT457415 | RPL36 | ribosomal protein L36 | 2 | 2 | ||||||||
MIRT457630 | UPK3BL | uroplakin 3B like 1 | 2 | 2 | ||||||||
MIRT458720 | VPS39 | VPS39, HOPS complex subunit | 2 | 2 | ||||||||
MIRT458745 | CES2 | carboxylesterase 2 | 2 | 2 | ||||||||
MIRT459269 | ADRBK1 | G protein-coupled receptor kinase 2 | 2 | 2 | ||||||||
MIRT459490 | CCL11 | C-C motif chemokine ligand 11 | 2 | 2 | ||||||||
MIRT460319 | SH3RF1 | SH3 domain containing ring finger 1 | 2 | 2 | ||||||||
MIRT461005 | SYT7 | synaptotagmin 7 | 2 | 2 | ||||||||
MIRT461579 | SCO1 | SCO1, cytochrome c oxidase assembly protein | 2 | 4 | ||||||||
MIRT461820 | SNAP23 | synaptosome associated protein 23 | 2 | 2 | ||||||||
MIRT463332 | ZFHX3 | zinc finger homeobox 3 | 2 | 2 | ||||||||
MIRT463449 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | 2 | 2 | ||||||||
MIRT464272 | VCL | vinculin | 2 | 2 | ||||||||
MIRT464895 | UBALD1 | UBA like domain containing 1 | 2 | 2 | ||||||||
MIRT465556 | TOB2 | transducer of ERBB2, 2 | 2 | 2 | ||||||||
MIRT466360 | THBS1 | thrombospondin 1 | 2 | 2 | ||||||||
MIRT466956 | STAT3 | signal transducer and activator of transcription 3 | 2 | 2 | ||||||||
MIRT467321 | SPATA2 | spermatogenesis associated 2 | 2 | 2 | ||||||||
MIRT467440 | SND1 | staphylococcal nuclease and tudor domain containing 1 | 2 | 2 | ||||||||
MIRT467823 | SLC29A2 | solute carrier family 29 member 2 | 2 | 2 | ||||||||
MIRT471173 | PHB2 | prohibitin 2 | 2 | 2 | ||||||||
MIRT471397 | PDPR | pyruvate dehydrogenase phosphatase regulatory subunit | 2 | 2 | ||||||||
MIRT471754 | OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | 2 | 2 | ||||||||
MIRT471846 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 2 | ||||||||
MIRT472020 | NPTXR | neuronal pentraxin receptor | 2 | 2 | ||||||||
MIRT472224 | NGFR | nerve growth factor receptor | 2 | 2 | ||||||||
MIRT472439 | NBL1 | neuroblastoma 1, DAN family BMP antagonist | 2 | 2 | ||||||||
MIRT472541 | NACC1 | nucleus accumbens associated 1 | 2 | 2 | ||||||||
MIRT473195 | MINOS1-NBL1 | MINOS1-NBL1 readthrough | 2 | 2 | ||||||||
MIRT473211 | MINK1 | misshapen like kinase 1 | 2 | 2 | ||||||||
MIRT473668 | MARCKSL1 | MARCKS like 1 | 2 | 2 | ||||||||
MIRT474852 | KHSRP | KH-type splicing regulatory protein | 2 | 2 | ||||||||
MIRT474939 | KCTD15 | potassium channel tetramerization domain containing 15 | 2 | 2 | ||||||||
MIRT477330 | EPHA2 | EPH receptor A2 | 2 | 2 | ||||||||
MIRT477395 | ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | 2 | 2 | ||||||||
MIRT477466 | ELMSAN1 | ELM2 and Myb/SANT domain containing 1 | 2 | 2 | ||||||||
MIRT477974 | DPM2 | dolichyl-phosphate mannosyltransferase subunit 2, regulatory | 2 | 2 | ||||||||
MIRT478331 | DDN | dendrin | 2 | 2 | ||||||||
MIRT479481 | CDK2 | cyclin dependent kinase 2 | 2 | 2 | ||||||||
MIRT481212 | ATXN7L3B | ataxin 7 like 3B | 2 | 2 | ||||||||
MIRT481263 | ATXN7L3 | ataxin 7 like 3 | 2 | 2 | ||||||||
MIRT481409 | ASXL1 | additional sex combs like 1, transcriptional regulator | 2 | 2 | ||||||||
MIRT482051 | AMD1 | adenosylmethionine decarboxylase 1 | 2 | 2 | ||||||||
MIRT482396 | AEN | apoptosis enhancing nuclease | 2 | 2 | ||||||||
MIRT483160 | PCSK2 | proprotein convertase subtilisin/kexin type 2 | 2 | 7 | ||||||||
MIRT483370 | CYP4A22 | cytochrome P450 family 4 subfamily A member 22 | 2 | 2 | ||||||||
MIRT483520 | QRSL1 | glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 | 2 | 4 | ||||||||
MIRT484059 | CYP4A11 | cytochrome P450 family 4 subfamily A member 11 | 2 | 2 | ||||||||
MIRT487075 | CLASP1 | cytoplasmic linker associated protein 1 | 2 | 4 | ||||||||
MIRT487421 | CACNB1 | calcium voltage-gated channel auxiliary subunit beta 1 | 2 | 2 | ||||||||
MIRT488359 | PAX2 | paired box 2 | 2 | 2 | ||||||||
MIRT488592 | ST7L | suppression of tumorigenicity 7 like | 2 | 2 | ||||||||
MIRT489556 | SOX11 | SRY-box 11 | 2 | 4 | ||||||||
MIRT489804 | KRT80 | keratin 80 | 2 | 4 | ||||||||
MIRT489865 | ATP2A3 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 | 2 | 2 | ||||||||
MIRT490014 | KIFC2 | kinesin family member C2 | 2 | 2 | ||||||||
MIRT490036 | PCSK4 | proprotein convertase subtilisin/kexin type 4 | 2 | 2 | ||||||||
MIRT491070 | ACVR1B | activin A receptor type 1B | 2 | 2 | ||||||||
MIRT494016 | DUSP9 | dual specificity phosphatase 9 | 2 | 2 | ||||||||
MIRT494816 | AKAP11 | A-kinase anchoring protein 11 | 2 | 2 | ||||||||
MIRT495991 | LTBP2 | latent transforming growth factor beta binding protein 2 | 2 | 2 | ||||||||
MIRT496272 | SLC2A13 | solute carrier family 2 member 13 | 2 | 2 | ||||||||
MIRT500454 | ZFP36L1 | ZFP36 ring finger protein like 1 | 2 | 2 | ||||||||
MIRT507989 | BCL2L13 | BCL2 like 13 | 2 | 4 | ||||||||
MIRT509713 | ANKRD23 | ankyrin repeat domain 23 | 2 | 2 | ||||||||
MIRT527984 | TSLP | thymic stromal lymphopoietin | 2 | 2 | ||||||||
MIRT530448 | SULT1B1 | sulfotransferase family 1B member 1 | 2 | 2 | ||||||||
MIRT531235 | FANCC | Fanconi anemia complementation group C | 2 | 2 | ||||||||
MIRT534590 | RPL28 | ribosomal protein L28 | 2 | 2 | ||||||||
MIRT535990 | MED28 | mediator complex subunit 28 | 2 | 4 | ||||||||
MIRT537280 | GABRA5 | gamma-aminobutyric acid type A receptor alpha5 subunit | 2 | 2 | ||||||||
MIRT539924 | DUSP28 | dual specificity phosphatase 28 | 2 | 2 | ||||||||
MIRT554711 | RNF146 | ring finger protein 146 | 2 | 2 | ||||||||
MIRT558962 | CAMSAP2 | calmodulin regulated spectrin associated protein family member 2 | 2 | 2 | ||||||||
MIRT568497 | ARHGDIA | Rho GDP dissociation inhibitor alpha | 2 | 2 | ||||||||
MIRT568875 | LY6H | lymphocyte antigen 6 family member H | 2 | 2 | ||||||||
MIRT568987 | CACNA1C | calcium voltage-gated channel subunit alpha1 C | 2 | 2 | ||||||||
MIRT569990 | TMEM184A | transmembrane protein 184A | 2 | 2 | ||||||||
MIRT570485 | THRA | thyroid hormone receptor, alpha | 2 | 2 | ||||||||
MIRT572826 | MYO1C | myosin IC | 2 | 2 | ||||||||
MIRT608199 | ERBB2 | erb-b2 receptor tyrosine kinase 2 | 2 | 2 | ||||||||
MIRT613220 | CCDC85C | coiled-coil domain containing 85C | 2 | 4 | ||||||||
MIRT629782 | PTDSS2 | phosphatidylserine synthase 2 | 2 | 2 | ||||||||
MIRT635332 | RASSF4 | Ras association domain family member 4 | 2 | 2 | ||||||||
MIRT653632 | SLC30A3 | solute carrier family 30 member 3 | 2 | 2 | ||||||||
MIRT664572 | GUF1 | GUF1 homolog, GTPase | 2 | 2 | ||||||||
MIRT667855 | IPCEF1 | interaction protein for cytohesin exchange factors 1 | 2 | 2 | ||||||||
MIRT668820 | CYLD | CYLD lysine 63 deubiquitinase | 2 | 2 | ||||||||
MIRT671274 | ETFDH | electron transfer flavoprotein dehydrogenase | 2 | 2 | ||||||||
MIRT681448 | CIITA | class II major histocompatibility complex transactivator | 2 | 2 | ||||||||
MIRT684817 | BRIX1 | BRX1, biogenesis of ribosomes | 2 | 2 | ||||||||
MIRT685861 | ANGEL1 | angel homolog 1 | 2 | 2 | ||||||||
MIRT688812 | CAPZB | capping actin protein of muscle Z-line beta subunit | 2 | 2 | ||||||||
MIRT691198 | NIF3L1 | NGG1 interacting factor 3 like 1 | 2 | 2 | ||||||||
MIRT696947 | CERK | ceramide kinase | 2 | 2 | ||||||||
MIRT699741 | SERBP1 | SERPINE1 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT701259 | NUP35 | nucleoporin 35 | 2 | 2 | ||||||||
MIRT701935 | MLLT1 | MLLT1, super elongation complex subunit | 2 | 2 | ||||||||
MIRT703332 | GDPD5 | glycerophosphodiester phosphodiesterase domain containing 5 | 2 | 2 | ||||||||
MIRT705519 | ARL6IP1 | ADP ribosylation factor like GTPase 6 interacting protein 1 | 2 | 2 | ||||||||
MIRT706065 | PKD1 | polycystin 1, transient receptor potential channel interacting | 2 | 2 | ||||||||
MIRT713238 | SV2B | synaptic vesicle glycoprotein 2B | 2 | 2 | ||||||||
MIRT714670 | CHRNE | cholinergic receptor nicotinic epsilon subunit | 2 | 2 | ||||||||
MIRT715001 | TSPAN11 | tetraspanin 11 | 2 | 2 | ||||||||
MIRT715356 | VCAM1 | vascular cell adhesion molecule 1 | 2 | 2 | ||||||||
MIRT715971 | FADS3 | fatty acid desaturase 3 | 2 | 2 | ||||||||
MIRT719585 | FNBP4 | formin binding protein 4 | 2 | 2 | ||||||||
MIRT719667 | DMRT2 | doublesex and mab-3 related transcription factor 2 | 2 | 2 | ||||||||
MIRT723360 | ASCL2 | achaete-scute family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT734985 | GADD45A | growth arrest and DNA damage inducible alpha | 2 | 0 | ||||||||
MIRT735022 | MMP19 | matrix metallopeptidase 19 | 3 | 0 | ||||||||
MIRT737359 | SATB2 | SATB homeobox 2 | 3 | 0 | ||||||||
MIRT756223 | MCM3 | minichromosome maintenance complex component 3 | 3 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|